Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-24-000017

Chief Financial Officer acquired 9,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
WENTWORTH KORY JAMES Chief Financial Officer 2024-03-15 Option exercise +9,000 $2.10 $18,900 83,170 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
WENTWORTH KORY JAMES Chief Financial Officer 2024-03-15 Option exercise · Stock Option (Right to Buy) −9,000 43,157 D: show line 2 in the form
Loading xslF345X05/wk-form4_1710880362.xml…